India's dealmaking landscape in the April-June quarter was dominated by a handful of blockbuster transactions, with Sun ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Organon’s portfolio includes more than 70 products across women’s health and general medicines, including biosimilars. The transaction has been approved by the Boards of Directors of both Sun Pharma ...

Sun Pharma's $11.75 billion Organon acquisition was much bigger than a typical pharma deal. Once people looked past the headline, the story became surprisingly interesting. The acquisition involved ...

India’s largest pharmaceutical company will acquire Jersey City-based drugmaker Organon & Co. in an all-cash deal valued at about $11.75 billion. Sun Pharma will buy Organon for $14 a share. The price ...

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the ...

The news: Mayne Pharma has appointed Meghan Rivera as a non-executive director, effective 26 June. The context: Rivera brings ...

After picking up European rights to a pair of Eli Lilly migraine meds in December, Organon, the women’s health-focused spinoff of Merck & Co., is hungry to ink more deals. “It’s not a one-off,” ...